Medican Enterprises Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Medican Enterprises last-minute Real Value cannot be determined due to lack of data. The latest price of Medican Enterprises is $0.0. Our model forecasts the value of Medican Enterprises from analyzing the firm fundamentals such as Shares Outstanding of 134.8 M, return on asset of -68.18, and Price To Sales of 2.72 X as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Medican Enterprises' price fluctuation is out of control at this time. Calculation of the real value of Medican Enterprises is based on 3 months time horizon. Increasing Medican Enterprises' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Medican Enterprises is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medican Pink Sheet. However, Medican Enterprises' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 |
The intrinsic value of Medican Enterprises' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medican Enterprises' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medican Enterprises helps investors to forecast how Medican pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medican Enterprises more accurately as focusing exclusively on Medican Enterprises' fundamentals will not take into account other important factors: Medican Enterprises Total Value Analysis
Medican Enterprises is now forecasted to have valuation of 7.77 M with market capitalization of 13.48 K, debt of 0, and cash on hands of 9.4 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Medican Enterprises fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.77 M | 13.48 K | 0 | 9.4 K |
Medican Enterprises Asset Utilization
One of the ways to look at asset utilization of Medican is to check how much profit was generated for every dollar of assets it reports. Medican Enterprises secures a negative usage of assets of -68.18 %, losing $0.68 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Medican Enterprises shows how discouraging it operates for each dollar spent on its assets.Medican Enterprises Ownership Allocation
Medican Enterprises maintains a total of 134.8 Million outstanding shares. Roughly 99.48 % of Medican Enterprises outstanding shares are held by general public with 0.52 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Medican Enterprises Profitability Analysis
Net Loss for the year was (56.52 M) with profit before overhead, payroll, taxes, and interest of 0.About Medican Enterprises Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Medican Enterprises. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Medican Enterprises based exclusively on its fundamental and basic technical indicators. By analyzing Medican Enterprises's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Medican Enterprises's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medican Enterprises. We calculate exposure to Medican Enterprises's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medican Enterprises's related companies.Medican Enterprises, Inc., a bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector. Medican Enterprises, Inc. was founded in 1988 and is headquartered in Las Vegas, Nevada. Medican Enterprises operates under Real Estate Services classification in the United States and is traded on OTC Exchange. It employs 3 people.
8 Steps to conduct Medican Enterprises' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Medican Enterprises' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Medican Enterprises' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Medican Enterprises' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Medican Enterprises' revenue streams: Identify Medican Enterprises' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Medican Enterprises' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Medican Enterprises' growth potential: Evaluate Medican Enterprises' management, business model, and growth potential.
- Determine Medican Enterprises' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Medican Enterprises' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Medican Enterprises Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Retained Earnings | -57.6 M |
Other Information on Investing in Medican Pink Sheet
Medican Enterprises financial ratios help investors to determine whether Medican Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medican with respect to the benefits of owning Medican Enterprises security.